U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07908147) titled 'Biomarker-guided RAdiation-deferring Treatment in Younger GBM Patients - Pilot Study' on Oct. 14.
Brief Summary: This study will investigate whether rapid molecular testing of recurrent glioblastoma (GBM) can identify tumour biomarkers that may help guide treatment selection in younger people with IDH-wildtype GBM. Participants will be people under 55 years of age whose diagnosis is consistent with glioblastoma and who have undergone recent surgery or previously participated in the initial phase of the BRAid GBM study.
Tumour tissue will undergo rapid molecular testing to identify biomarkers that may predict response to specific ta...